Dr. Tami Rachmilewitz is a clinical research physician executive with over 20 years of experience in the Pharmaceutical Industry. Prior to joining ImmuneWalk she served as the Senior Vice President of Clinical Development at VBL Therapeutics responsible for all clinical aspects of the company’s development programs.
Prior to VBL, Dr. Rachmilewitz held medical positions at Teva, Novartis & Neuroderm, working on early and late stage programs, mainly in the therapeutic areas of Neurology and Immunology. She holds an MD from the Medical School at the Hebrew University in Jerusalem, and trained in Psychiatry at the Hadassah Medical Center in Jerusalem.
Copyright © 2024 ImmuneWalk Therapeutics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.